Company Filing History:
Years Active: 2017
Title: David Shum: Innovator in Cancer Research
Introduction
David Shum is a notable inventor based in Forest Hills, NY (US). He has made significant contributions to the field of cancer research through his innovative work on pharmaceutical compounds.
Latest Patents
David Shum holds a patent for "Substituted pyridazines as EGFR and/or KRAS inhibitors." This invention is directed to pyridazinone compounds of formula (I) and furan compounds of formula (II). The patent includes pharmaceutical compositions of these compounds, kits containing them, methods of synthesis, and a method of treatment for proliferative diseases by administering a therapeutically effective amount of the compounds. Both classes of compounds were identified through screening of a collection of small molecule libraries.
Career Highlights
David Shum is affiliated with the Sloan-Kettering Institute for Cancer Research, where he continues to advance his research in the field. His work focuses on developing innovative treatments for cancer, contributing to the ongoing fight against this disease.
Collaborations
Some of his notable coworkers include Hakim Djaballah and Harold E. Varmus, who have also made significant contributions to cancer research.
Conclusion
David Shum's innovative work and patent in the field of cancer research highlight his commitment to improving treatment options for patients. His contributions are vital in the ongoing battle against cancer.